At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Expanded MedStar Diabetes Pathway Ongoing Chart Review Protocol
In Brief
An observational study evaluating Intensive diabetes education and medication management for Type2 Diabetes Mellitus. Completed, enrolled 826 participants.
Detailed Summary
The MedStar Diabetes Pathway (MDP) is transitioning into a clinical program offered at various MedStar sites. The MDP clinical team is reviewing the data collected during the pilot to improve the program and adapt it to various clinical settings in order to better serve the target patient population. It is imperative to continue reviewing patient clinical outcomes as the program expands in order to insure continuous quality improvement of the program. This will be achieved through chart reviews of patients receiving diabetes care via the MDP and comparison with patients received diabetes standard of care through their primary care physician.
Study Details
Timeline
Interventions
Patients receive intensive knowledge based diabetes education and algorithm driven medication management over a period of 12 weeks.